Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) Revenue: 2023-2025

Historic Revenue for Inhibrx Biosciences (INBX) over the last 3 years, with Sep 2025 value amounting to -$3.2 million.

  • Inhibrx Biosciences' Revenue was N/A to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.9 million, marking a year-over-year change of. This contributed to the annual value of $200,000 for FY2024, which is 88.89% down from last year.
  • Inhibrx Biosciences' Revenue amounted to -$3.2 million in Q3 2025, which was down 1.27% from -$3.1 million recorded in Q2 2025.
  • Inhibrx Biosciences' Revenue's 5-year high stood at $1.6 million during Q4 2023, with a 5-year trough of -$8.1 million in Q1 2024.
  • In the last 3 years, Inhibrx Biosciences' Revenue had a median value of -$2.7 million in 2025 and averaged -$2.3 million.
  • As far as peak fluctuations go, Inhibrx Biosciences' Revenue plummeted by 31,635.29% in 2024, and later surged by 66.92% in 2025.
  • Quarterly analysis of 3 years shows Inhibrx Biosciences' Revenue stood at $1.6 million in 2023, then plummeted by 93.88% to $100,000 in 2024, then spiked by 41.41% to -$3.2 million in 2025.
  • Its Revenue was -$3.2 million in Q3 2025, compared to -$3.1 million in Q2 2025 and -$2.7 million in Q1 2025.